Latest News and Press Releases
Want to stay updated on the latest news?
-
VLN® cigarettes from 22nd Century Group contain 95% less nicotine than conventional cigarettes, greatly reducing nicotine consumption to help smokers smoke less; support State and FDA goals of...
-
BUFFALO, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
-
BUFFALO, N.Y., Nov. 11, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
-
Meeting Held October 14 with Senior Level Staff at FDACompany’s Confidence in a Positive MRTP Application Outcome and Timing at Its Highest LevelMonetizing Hemp/Cannabis Plant Lines and IP Beginning...
-
22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and...
-
Company Supports This Week’s Positive FDA Action on E-Cigarettes, Demonstrating the Agency’s Commitment to Providing Adult Smokers with Alternatives to Highly Addictive CigarettesApplauds FDA’s Active...
-
BUFFALO, N.Y., Oct. 01, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and...
-
BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and...
-
BUFFALO, N.Y., Aug. 30, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant biotechnology and intellectual property company focused on improving health and wellness...
-
WILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...